TY - JOUR
T1 - Impaired neoangiogenesis in β2-adrenoceptor gene-deficient mice
T2 - Restoration by intravascular human β2-adrenoceptor gene transfer and role of NFkB and CREB transcription factors
AU - Ciccarelli, Michele
AU - Sorriento, Daniela
AU - Cipolletta, Ersilia
AU - Santulli, Gaetano
AU - Fusco, Anna
AU - Zhou, Rui Hai
AU - Eckhart, Andrea D.
AU - Peppel, Karsten
AU - Koch, Walter J.
AU - Trimarco, Bruno
AU - Iaccarino, Guido
PY - 2011/2
Y1 - 2011/2
N2 - Background and Purpose: There is much evidence supporting the role of β 2-adrenoceptors (β 2AR) in angiogenesis but the mechanisms underlying their effects have not been elucidated. Hence, we studied post-ischaemic angiogenesis in the hindlimb (HL) of β 2AR knock-out mice (β 2AR-/-) in vivo and explored possible molecular mechanisms in vitro. Experimental Approach: Femoral artery resection (FAR) was performed in wild-type and β 2AR-/-mice and adaptive responses to chronic HL ischaemia were explored; blood flow was measured by ultrasound and perfusion of dyed beads, bone rarefaction, muscle fibrosis and skin thickness were evaluated by immunoflourescence and morphometric analysis. Intrafemoral delivery of an adenovirus encoding the human β 2AR (ADβ 2AR) was used to reinstate β 2ARs in β 2AR-/-mice. Molecular mechanisms were investigated in mouse-derived aortic endothelial cells (EC) in vitro, focusing on NFκB activation and transcriptional activity. RESULTS Angiogenesis was severely impaired in β 2AR-/-mice subjected to FAR, but was restored by gene therapy with ADβ 2AR. The proangiogenic responses to a variety of stimuli were impaired in β 2AR-/-EC in vitro. Moreover, removal of β 2ARs impaired the activation of NFκB, a transcription factor that promotes angiogenesis; neither isoprenaline (stimulates βARs) nor TNFα induced NFκB activation in β 2AR -/-EC. Interestingly, cAMP response element binding protein (CREB), a transcription factor that counter regulates NFκB, was constitutively increased in β 2AR -/-ECs. ADβ 2AR administration restored β 2AR membrane density, reduced CREB activity and reinstated the NFκB response to isoprenaline and TNFα. Conclusions and Implications: Our results suggest that β 2ARs control angiogenesis through the tight regulation of nuclear transcriptional activity.
AB - Background and Purpose: There is much evidence supporting the role of β 2-adrenoceptors (β 2AR) in angiogenesis but the mechanisms underlying their effects have not been elucidated. Hence, we studied post-ischaemic angiogenesis in the hindlimb (HL) of β 2AR knock-out mice (β 2AR-/-) in vivo and explored possible molecular mechanisms in vitro. Experimental Approach: Femoral artery resection (FAR) was performed in wild-type and β 2AR-/-mice and adaptive responses to chronic HL ischaemia were explored; blood flow was measured by ultrasound and perfusion of dyed beads, bone rarefaction, muscle fibrosis and skin thickness were evaluated by immunoflourescence and morphometric analysis. Intrafemoral delivery of an adenovirus encoding the human β 2AR (ADβ 2AR) was used to reinstate β 2ARs in β 2AR-/-mice. Molecular mechanisms were investigated in mouse-derived aortic endothelial cells (EC) in vitro, focusing on NFκB activation and transcriptional activity. RESULTS Angiogenesis was severely impaired in β 2AR-/-mice subjected to FAR, but was restored by gene therapy with ADβ 2AR. The proangiogenic responses to a variety of stimuli were impaired in β 2AR-/-EC in vitro. Moreover, removal of β 2ARs impaired the activation of NFκB, a transcription factor that promotes angiogenesis; neither isoprenaline (stimulates βARs) nor TNFα induced NFκB activation in β 2AR -/-EC. Interestingly, cAMP response element binding protein (CREB), a transcription factor that counter regulates NFκB, was constitutively increased in β 2AR -/-ECs. ADβ 2AR administration restored β 2AR membrane density, reduced CREB activity and reinstated the NFκB response to isoprenaline and TNFα. Conclusions and Implications: Our results suggest that β 2ARs control angiogenesis through the tight regulation of nuclear transcriptional activity.
KW - NFkB activity
KW - adrenergic signaling
KW - gene therapy
KW - ischaemic hindlimb
UR - http://www.scopus.com/inward/record.url?scp=78651417065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651417065&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5381.2010.01078.x
DO - 10.1111/j.1476-5381.2010.01078.x
M3 - Article
C2 - 20958287
AN - SCOPUS:78651417065
SN - 0007-1188
VL - 162
SP - 712
EP - 721
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 3
ER -